A Phase I Study of an mRNA-Modified Dendritic Cell Vaccine in Patients with Melanoma
[Protocol 10-229] |
Young, James |
|
A Phase I Study of Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
[Protocol 09-011] |
Modak, Shakeel |
|
A Phase I Study of ASG-5ME Therapy Patients with Advanced Prostate Cancer
[Protocol 10-138] |
Morris, Michael |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
A Phase I Study of AT13387 Alone or with Abiraterone to Treat Castration-Resistant Prostate Cancer that Continues Growing Despite Abiraterone
[Protocol 12-248] |
Slovin, Susan |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
A Phase I Study of Axitinib plus Dalantercept for Patients with Metastatic Kidney Cancer
[Protocol 12-255] |
Voss, Martin |
|
A Phase I Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancer
[Protocol 11-170] |
Paik, Paul |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase I Study of AZD6244 in Pediatric Patients with Recurrent or Refractory Low-Grade Glioma (PBTC-029)
[Protocol 12-151] |
Dunkel, Ira |
|
A Phase I Study of BI 836858 in Patients with Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 12-133] |
Tallman, Martin |
- Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
|
A Phase I Study of BKM120 and Olaparib in Patients with High-Grade Serous Ovarian Cancer
[Protocol 12-233] |
Bell-McGuinn, Katherine |
- Breast Cancer
- Ovarian Cancer
|
A Phase I Study of BKM120 with Carboplatin and Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 10-192] |
Fury, Matthew |
|
A Phase I Study of Blinatumomab in Children and Adolescents with Relapsed/Refractory Acute Lymphoblastic Leukemia
[Protocol 12-044] |
Trippett, Tanya |
- Leukemia
- Acute Lymphoblastic Leukemia
|
A Phase I Study of BMS-663513 (Anti-CD137 Antibody) in Patients with Advanced or Metastatic Solid Tumors
[Protocol 11-212] |
Segal, Neil |
|
A Phase I Study of BMS-906024 in Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma
[Protocol 11-181] |
Douer, Dan |
- Leukemia
- Acute Lymphoblastic Leukemia
- Lymphoma
|
A Phase I Study of BMS-936558 in Combination with Sunitinib or Pazopanib in Patients with Metastatic Renal Cell Carcinoma
[Protocol 12-147] |
Voss, Martin |
|
A Phase I Study of BMS-936558 in Patients with Relapsed or Refractory Hematologic Cancers
[Protocol 12-142] |
Lesokhin, Alexander |
- Hematology
- Leukemia
- Chronic Myelocytic Leukemia
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
|
A Phase I Study of BMS-936558 with Combination Chemotherapy for Patients with Previously Untreated Stage IIIB or IV Non-Small Cell Lung Cancer
[Protocol 11-189] |
Rizvi, Naiyer |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase I Study of BMS-986015 plus BMS-936558 in Patients with Advanced Solid Tumors
[Protocol 12-224] |
Segal, Neil |
- Colorectal Cancer
- Kidney Cancer
- Lung Cancer, Non-Small Cell
- Melanoma
- Ovarian Cancer
|
A Phase I Study of BMS-986015 with Ipilimumab in Patients with Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Melanoma
[Protocol 12-283] |
Rizvi, Naiyer |
- Lung Cancer, Non-Small Cell
- Melanoma
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
- Solid Tumors
|
A Phase I Study of Cabazitaxel in Children and Teens with Persistent Solid Tumors
[Protocol 13-021] |
Trippett, Tanya |
- Pediatric Brain Tumors
- Primary Bone
- Sarcomas
- Solid Tumors
|
A Phase I Study of Carboplatin/Paclitaxel/Bevacizumab and ABT-888 in Patients with Previously Untreated Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 09-106] |
Bell-McGuinn, Katherine |
|
